What is the current Price Target for the Cellectis SA Sponsored ADR stock?

The average Cellectis SA Sponsored ADR target price is $7.65. This is 73.86% higher than the current stock price. The highest price target is 78.97%, the lowest is 72.15%. 3 Analysts have issued a price target Cellectis SA Sponsored ADR 2026 .

How high will the Cellectis SA Sponsored ADR stock rise?

No reliable answer can be given as to how high the Cellectis SA Sponsored ADR stock will rise. The performance of stocks, including the Cellectis SA Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cellectis SA Sponsored ADR stock today?

The performance of Cellectis SA Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cellectis SA Sponsored ADR stock fall?

The decline in Cellectis SA Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cellectis SA Sponsored ADR Forecast, price target & analysts

$4.81

9.20% today

Nasdaq, Nov 20, 07:16 pm CET

ISIN

US15117K1034

Symbol

CLLS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Cellectis SA Sponsored ADR Target price 2025 - Analyst rating & recommendation

Cellectis SA Sponsored ADR Classifications & Recommendation:

Buy

85%

Hold

15%

Cellectis SA Sponsored ADR Price Target

Target Price	$7.65
Price	$4.40
Potential	73.86% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Cellectis SA Sponsored ADR 2026 . The average Cellectis SA Sponsored ADR target price is $7.65. This is 73.86% register free of charge higher than the current stock price. The highest price target is $7.87 78.97% register free of charge , the lowest is $7.57 72.15% register free of charge .
	A rating was issued by 13 analysts: 11 Analysts recommend Cellectis SA Sponsored ADR to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cellectis SA Sponsored ADR stock has an average upside potential 2026 of 73.86% register free of charge . Most analysts recommend the Cellectis SA Sponsored ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	49.22	43.29
	435.58%	12.06%
EBITDA Margin	-80.62%	-202.50%
	90.60%	151.19%

8 Analysts have issued a sales forecast Cellectis SA Sponsored ADR 2025 . The average Cellectis SA Sponsored ADR sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$49.2m	435.58%
2025	$43.3m 12.06% Unlock
2026	$68.4m 58.00% Unlock
2027	$59.6m 12.88% Unlock
2028	$82.5m 38.43% Unlock
2029	$138m 66.92% Unlock
2030	$187m 35.69% Unlock
2031	$224m 20.03% Unlock
2032	$296m 32.18% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.41	-1.10
	76.84%	168.29%
P/E		negative

8 Analysts have issued a Cellectis SA Sponsored ADR forecast for earnings per share. The average Cellectis SA Sponsored ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.41	76.84%
2025	$-1.10 168.29% Unlock
2026	$-1.17 6.36% Unlock
2027	$-1.28 9.40% Unlock

Current	-5.79	200.32%
2025	-4.00 30.91% Unlock
2026	-3.76 6.00% Unlock
2027	-3.45 8.24% Unlock

Cellectis SA Sponsored ADR...

Current Cellectis SA Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Barclays	Locked ➜ Locked	Locked	Oct 17 2025
CITIZENS	Locked ➜ Locked	Locked	Aug 07 2025
ODDO BHF	Locked ➜ Locked	Locked	Aug 05 2025
CITIZENS	Locked ➜ Locked	Locked	May 26 2025
CITIZENS	Locked ➜ Locked	Locked	May 25 2025
ODDO BHF	Locked ➜ Locked	Locked	May 13 2025
ODDO BHF	Locked ➜ Locked	Locked	May 12 2025

Analyst Rating	Date
Locked Barclays: Locked ➜ Locked	Oct 17 2025
Locked CITIZENS: Locked ➜ Locked	Aug 07 2025
Locked ODDO BHF: Locked ➜ Locked	Aug 05 2025
Locked CITIZENS: Locked ➜ Locked	May 26 2025
Locked CITIZENS: Locked ➜ Locked	May 25 2025
Locked ODDO BHF: Locked ➜ Locked	May 13 2025
Locked ODDO BHF: Locked ➜ Locked	May 12 2025

Discover more stocks with a high price target

Netflix 1,188.91%

Coinbase Global, Inc. 60.16%

Adidas 57.44%

TUI 53.15%

Meta Platforms (Facebook) 51.19%

Novo Nordisk 48.54%

BYD 43.53%

Deutsche Telekom 43.13%

Adyen 42.77%

BioNTech SE - ADR 37.27%

Rheinmetall 37.08%

Walt Disney 34.48%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now